BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37061835)

  • 1. Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy.
    Cheng X; Chen B; Wang S; Zhang J; Zhu J; Liu M; Liu S; Xi M
    Oncologist; 2023 Aug; 28(8):e606-e616. PubMed ID: 37061835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes.
    Xu H; Lin M; Hu Y; Zhang L; Li Q; Zhu J; Wang S; Xi M
    Oncologist; 2021 Mar; 26(3):e425-e434. PubMed ID: 32960471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.
    Davuluri R; Jiang W; Fang P; Xu C; Komaki R; Gomez DR; Welsh J; Cox JD; Crane CH; Hsu CC; Lin SH
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):128-135. PubMed ID: 28816138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort.
    Qi WX; Wang X; Li C; Li S; Li H; Xu F; Chen J; Zhao S; Li H
    Thorac Cancer; 2023 Jun; 14(17):1556-1566. PubMed ID: 37089116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients.
    Wang X; Zhao Z; Wang P; Geng X; Zhu L; Li M
    Front Oncol; 2020; 10():997. PubMed ID: 32656085
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs.
    Tseng I; Ai D; Chen Y; Zhu H; Li F; Xu Y; Yu L; Liu Q; Deng J; Hao S; Zhu Z; Zhao W; Fan M; Li L; Su F; Zhao K
    Radiat Oncol; 2023 Oct; 18(1):172. PubMed ID: 37858121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma.
    Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J
    Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count.
    Xie X; Gong S; Jin H; Yang P; Xu T; Cai Y; Guo C; Zhang R; Lou F; Yang W; Wang H
    Radiat Oncol; 2020 Mar; 15(1):65. PubMed ID: 32169088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy.
    Zhou XL; Zhu WG; Zhu ZJ; Wang WW; Deng X; Tao WJ; Ji FZ; Tong YS
    Oncologist; 2019 Aug; 24(8):e677-e686. PubMed ID: 31040254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy.
    Zhang T; Guo Z; Chen X; Dong J; Jiang H; Tang P; Wang P; Qian D; Zhang W; Pang Q
    Radiat Oncol; 2022 Aug; 17(1):148. PubMed ID: 35999608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less Irradiation to Lymphocyte-Related Organs Reduced the Risk of G4 Lymphopenia in Esophageal Cancer: Re-Analysis of Prospective Trials.
    Tseng I; Li F; Ai D; Chen Y; Xu Y; Yu L; Hao S; Zhu H; Deng J; Liu Q; Pan F; Su F; Zhao K
    Oncologist; 2023 Aug; 28(8):e645-e652. PubMed ID: 37285035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer.
    Fang P; Jiang W; Davuluri R; Xu C; Krishnan S; Mohan R; Koong AC; Hsu CC; Lin SH
    Radiother Oncol; 2018 Sep; 128(3):584-590. PubMed ID: 29530432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment-related lymphopenia impairs the treatment response of anti-PD-1 therapy in esophageal squamous cell carcinoma.
    Yin T; Wang P; Yu J; Teng F
    Int Immunopharmacol; 2022 May; 106():108623. PubMed ID: 35203044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?
    Chadha AS; Liu G; Chen HC; Das P; Minsky BD; Mahmood U; Delclos ME; Suh Y; Sawakuchi GO; Beddar S; Katz MH; Fleming JB; Javle MM; Varadhachary GR; Wolff RA; Crane CH; Wang X; Thames H; Krishnan S
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):323-332. PubMed ID: 28068240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers.
    Wu Y; Chen J; Zhao L; Li Q; Zhu J; Yang H; Guo S; Xi M
    Cancer Res Treat; 2021 Jan; 53(1):172-183. PubMed ID: 32898941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Lymphopenia and Dosimetric Parameters on Overall Survival of Esophageal Cancer Patients Treated with Definitive Radiotherapy.
    Liu M; Li X; Cheng H; Wang Y; Tian Y
    Cancer Manag Res; 2021; 13():2917-2924. PubMed ID: 33833575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy.
    Zhao Z; Zhang Y; Wang X; Geng X; Zhu L; Li M
    Cancer Med; 2020 Aug; 9(16):5881-5888. PubMed ID: 32627960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy.
    Chen D; Patel RR; Verma V; Ramapriyan R; Barsoumian HB; Cortez MA; Welsh JW
    Radiother Oncol; 2020 Sep; 150():114-120. PubMed ID: 32525003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab.
    Chen B; Liu S; Zhu Y; Wang R; Cheng X; Chen B; Dragomir MP; Zhang Y; Hu Y; Liu M; Li Q; Yang H; Xi M
    Nat Commun; 2024 Mar; 15(1):1919. PubMed ID: 38429311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes and toxicities of locally advanced esophageal squamous cell carcinoma patients treated with early thoracic radiation therapy after induction chemotherapy.
    Qiu J; Lin H; Yu Y; Ke D; Li H; Zheng H; Zheng Q; Wang Z; Lin M; Yang J; Liu L; Zhang M; Liu T; Wu Y; Li J; Lai J
    Int J Clin Oncol; 2023 Apr; 28(4):550-564. PubMed ID: 36735115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.